Baker & Eastlack Ventures
Baker & Eastlack Ventures
  • Home
  • About
  • Portfolio
  • Investment Focus
  • News
  • Contact
February 16 2019

CMS now covers Clarify’s phototherapy psoriasis treatment

The CMS has issued a decision granting reimbursement for procedures with Clarify Medical’s Clarify Home light therapy system for psoriasis treatment under the agency’s National Coverage Determination. The handheld, home-use system, which can sync with a smartphone, decelerates the growth of affected skin cells using narrowband ultraviolet B rays.

Read the entire article: https://www.ris.world/usa-cms-now-covers-clarifys-phototherapy-psoriasis-treatment/

Kurin, Inc. Receives FDA 510(k) Clearance for Its Novel Kurin Lock with Peripheral IV Infusion Set ControlRadâ„¢ Secures $15 Million Series B Financing, Expands Board of Directors

Related Posts

Uncategorized

Micron Medical Appoints Seasoned Healthcare Executive Mark Landy as Chief Executive Officer

Uncategorized

Zerigo Now Approved as a MultiPlan Participating Provider

Uncategorized

Spinal Singularity Hires New CEO

Baker & Eastlack Ventures

Contact Us

Email: bakerandeastlack@gmail.com

© Baker & Eastlack Ventures 2023